Al-Khair Creative Quality Ware
FDA import alert and refusal historyKarachi, PakistanFEI 3004063371
Recorded by FDA as AL-KHAIR CREATIVE QUALITY WARE
As of October 25, 2026, Al-Khair Creative Quality Ware (Karachi, Pakistan) is on the red list of FDA Import Alert 36-04 (Honey and blended syrup: drug residues) for honey, published by FDA on October 2, 2026, and has no FDA import refusals recorded since October 2016.
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- IA 36-04 · red list
- Last import refusal
- None since October 2016
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Al-Khair Creative Quality Ware
1 record, newest first. Each line links to the FDA page it came from.
2026
- Import alert listingListed on Import Alert 36-04red listHoneySource
Questions about Al-Khair Creative Quality Ware
- Is Al-Khair Creative Quality Ware on an FDA import alert?
- Yes. As of October 25, 2026, Al-Khair Creative Quality Ware is on the red list of FDA Import Alert 36-04, “Honey and blended syrup: drug residues”, for honey; FDA published the listing on October 2, 2026.
- Has FDA refused shipments from Al-Khair Creative Quality Ware?
- No FDA import refusals for Al-Khair Creative Quality Ware appear in FDA's refusal data since October 2016, as of October 25, 2026.
- What is Al-Khair Creative Quality Ware's FEI number?
- Al-Khair Creative Quality Ware's FDA Establishment Identifier (FEI) is 3004063371.
- Can shipments from Al-Khair Creative Quality Ware still enter the U.S.?
- Shipments of honey from Al-Khair Creative Quality Ware can be detained without physical examination under Import Alert 36-04; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).
Buying from Al-Khair Creative Quality Ware?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.